Biological Information
Background Information:
Five subtypes of dopamine receptors, D1, D2, D3, D4 and D5, were identified on the basis of pharmacological or biochemical criteria. The D2-like receptors include the two isoforms of the D2 receptor, differing in the length of their predicted third cytoplasmic loop, dubbed D2 short (D2S) and D2 long (D2L). The dopamine D2S receptor couples to PTX-sensitive G proteins (Gi/o) to initiate multiple signaling pathways. In cells of neuroendocrine origin, the D2S couples to "inhibitory" pathways, including inhibition of adenylyl cyclase, activation of potassium channels to hyperpolarize the cell membrane, and inhibition of L-type calcium channels, which in concert mediate inhibition of hormone secretion and gene transcription, and inhibition of cell proliferation. D2 dopamine receptors have been implicated in the pathophysiology of schizophrenia and Parkinson’s disease.
PathHunter β-Arrestin GPCR cell lines are engineered to co-express the ProLink™ (PK) tagged GPCR and the Enzyme Acceptor (EA) tagged β-Arrestin. Activation of the GPCR-PK induces β-Arrestin-EA recruitment, forcing complementation of the two β-galactosidase enzyme fragments (EA and PK). The resulting functional enzyme hydrolyzes substrate to generate a chemiluminescent signal.
Family:
GPCR
Sub Family:
Dopamine
Class:
Class A
Coupling:
Gi/Go
Protein Name:
D2
Uniprot Number:
P14416
Gene Name:
DRD2
Gene ID:
1813
Accession Number:
NM_016574.3
Organism:
Human
Cell Type:
CHO-K1
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Functional Mode:
Agonist
β-Arrestin Isoform:
β-Arrestin-2
Testing Information
Control Activator:
Dopamine
Test Concentration / Dose:
Eurofins will provide IC/EC50 calculation if 10 concentrations are selected
Test Sample Requirements:
40uL of a 1000X stock for the first assay and 2uL for each additional assay (assay = 1 target, 1 readout, 1 mode)
Minimum Order Quantity:
20
Turnaround Time
Standard:
15 Business Days
Clinical Relevance
Adverse / Beneficial Action:
Dopamine D2 receptor antagonist may be used in the treatment of psychosis; may also result in tardive dyskinesia and increase pituitary hormone secretion.
Additional Information
Brand:
LeadHunter
Testing Location:
USA - Fremont, CA